A nationwide recall of more than 40,000 units of toothpaste has received the lowest risk level by the Food and Drug Administration. A recall for Sensodyne Pronamel Active Shield Toothpaste for Sensitive Teeth began on August 5 over concerns that "Fresh Mint" tubes were mislabeled "Cool Mint/Whitening." The outer carton was labeled accurately.

The approval makes Wegovy the only GLP-1 therapy cleared to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis. About 14.9 million U.S. adults — or roughly 6% of the population — have the condition, according to the FDA.

The hits just keep on coming for Regeneron’s Eylea franchise. | The FDA has extended its target action dates for two applications to expand the use of Eylea’s high-dose formulation. The U.S. regulator was originally scheduled to make its Eylea HD decisions by Aug.

After a more than decadelong process to bring the experimental drug elamipretide to market, the treatment’s approval has repeatedly hit roadblocks.

E (Nasdaq:NVNO) announced today that it received a not-approvable letter from the FDA related to its VenoValve.

NSCLC represents 80% of lung cancer cases and is the leading cause of cancer-related mortality globally. This designation is intended for patients with EGFR exon 19 deletions or e

In light of this, dermatologist Adam Friedman of the George Washington University has shared with Newsweek how you can choose safe and effective protection.

The clinical hold is due to questions about BX004’s nebulizer device, temporarily pausing US enrollment in the cystic fibrosis Phase IIb trial (NCT06998043) while European dosing continues.